Follow
Owen Muir, M.D., DFAACAP
Owen Muir, M.D., DFAACAP
Fermata
Verified email at fermata.health - Homepage
Title
Cited by
Cited by
Year
When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature
P Manu, D Sarpal, O Muir, JM Kane, CU Correll
Schizophrenia research 134 (2-3), 180-186, 2012
1802012
Blogging and social media for mental health education and advocacy: a review for psychiatrists
HS Peek, M Richards, O Muir, SR Chan, M Caton, C MacMillan
Current psychiatry reports 17, 1-8, 2015
492015
Real-world efficacy of deep TMS for obsessive-compulsive disorder: post-marketing data collected from twenty-two clinical sites
Y Roth, A Tendler, MK Arikan, R Vidrine, D Kent, O Muir, C MacMillan, ...
Journal of psychiatric research 137, 667-672, 2021
482021
Deep TMS H1 Coil treatment for depression: Results from a large post marketing data analysis
A Tendler, S Goerigk, S Zibman, S Ouaknine, T Harmelech, GS Pell, ...
Psychiatry Research 324, 115179, 2023
102023
Real world efficacy and safety of various accelerated deep TMS protocols for major depression
Y Roth, CA Hanlon, G Pell, S Zibman, T Harmelech, OS Muir, C MacMillan, ...
Psychiatry Research 328, 115482, 2023
92023
Long-term outcomes of a course of deep TMS for treatment-resistant OCD
T Harmelech, A Tendler, MK Arikan, HL Çetin, MT Esmeray, R Ilhan, ...
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2022
42022
Mental health clinicians’ attitudes toward narcissistic personality disorder.
O Muir, JN Weinfeld, D Ruiz, D Ostrovsky, M Fiolhais, C MacMillan
Personality Disorders: Theory, Research, and Treatment 12 (5), 389, 2021
32021
Attitudes of children and adolescents and their caregivers towards long-acting injectable antipsychotics in a cohort of youth initiating oral antipsychotic treatment
CU Correll, O Muir, A Al-Jadiri, S Kapoor, M Carella, E Sheridan, L David, ...
Neuropsychopharmacology 38, S280-S280, 2013
32013
Deep TMS for major depression, interim post-marketing analysis of 1040 patients.
SA Harvey, A Tendler, M DeLuca, J Stehberg, R Naimark, D Schmidt, ...
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2020
22020
Real-world efficacy of deep TMS for obsessive-compulsive disorder: interim post-marketing analysis of 192 patients from twenty-two sites
G Grammer, A Tendler, MK Arikan, R Vidrine, D Kent, O Muir, C MacMillan, ...
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2020
12020
Mentalization-Based Treatment for Adolescents: The Framework for Work with Suicide and Self-Injurious Behaviors
T Rossouw, O Muir, LL Williams
Adolescent Suicide and Self-Injury: Mentalizing Theory and Treatment, 125-136, 2020
12020
Rapid remission of depression using sequential bilateral theta burst dTMS
O Muir, C MacMillan, M Khan, L Sang, T Aron
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2019
12019
Safety and tolerability of dTMS treatment in 18-20 year old patients: case series
O Muir, C MacMillan, M Khan, L Sang, T Aron
Brain Stimulation: Basic, Translational, and Clinical Research in …, 2019
12019
Fundamentals in mentalization-based treatment for suicidal and self-injurious youth
LL Williams, C MacMillan, K McEvoy, C Grimes, E Bleiberg, OS Muir, ...
65th Annual Meeting, 2018
12018
Basic Concepts in Mentalizing Therapy With Adolescents With Emerging Personality Disorders and Self-Harming Behaviors
LL Williams, OS Muir, K McEvoy, E Bleiberg, C MacMillan, C Grimes, ...
65th Annual Meeting, 2018
12018
Borderline personality disorder: a case-based approach
B Palmer, B Unruh
Springer, 2018
12018
Good Psychiatric Management (GPM) for Personality Disorders in Young People
OS Muir
64th Annual Meeting, 2017
12017
11.1 Understanding mentalization-based treatment for adolescents
OS Muir
Journal of the American Academy of Child & Adolescent Psychiatry 10 (55), S17, 2016
12016
Psychedelic Therapy: A Primer for Primary Care Clinicians—3, 4-Methylenedioxy-methamphetamine (MDMA)
K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e141-e154, 2024
2024
Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics
OS Muir, K Shinozuka, BD Beutler, A Arenas, K Cherian, VD Evans, ...
American Journal of Therapeutics 31 (2), e178-e182, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20